HRMY
Harmony Biosciences Holdings
41.50$
-1.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 26.3% | 17.4% | 18.2% | 19.1% | 20.8% | 21.9% | 22.8% | |
| – | 73.7% | 82.6% | 81.8% | 80.9% | 79.2% | 78.1% | 77.2% | |
| – | 1,160.9% | 12.2% | 9.9% | 16.2% | 13.1% | 20.4% | 21.8% | |
| – | 607.3% | 24.9% | 20.9% | 19.2% | 16.4% | 15.4% | 17.6% | |
| – | 2,507.5% | 72.0% | 53.2% | 53.5% | 46.2% | 51.4% | 53.2% | |
| – | -2,433.8% | 10.6% | 28.7% | 27.4% | 33.0% | 26.7% | 24.0% | |
| – | 101.3% | 17.7% | 7.9% | 4.3% | 4.1% | 2.4% | 1.7% | |
| – | -2,535.1% | -23.1% | 12.3% | 23.9% | 29.8% | 26.8% | 24.8% | |
| – | 101.3% | 9.3% | 0.9% | -17.5% | 7.7% | 6.5% | 6.5% | |
| – | -2,535.1% | -23.1% | 11.3% | 41.4% | 22.1% | 20.4% | 18.3% | |
| – | -2,380.2% | 0.9% | 26.3% | 33.5% | 38.1% | 32.7% | 29.4% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.